blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2444069

EP2444069 - Controlled release compositions [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.04.2020
Database last updated on 24.04.2024
FormerThe patent has been granted
Status updated on  03.05.2019
FormerGrant of patent is intended
Status updated on  13.12.2018
FormerExamination is in progress
Status updated on  27.04.2018
Most recent event   Tooltip09.07.2021Lapse of the patent in a contracting state
New state(s): HU		published on 11.08.2021  [2021/32]
Applicant(s)For all designated states
Evonik Corporation
299 Jefferson Road
Parsippany NJ 07054 / US
[2013/39]
Former [2012/33]For all designated states
Surmodics Pharmaceuticals, Inc.
756 Tom Martin Drive
Birmingham AL 35211 / US
Former [2012/17]For all designated states
PR Pharmaceuticals Inc.
1716 Heath Parkway
Fort Collins, CO 80522 / US
Inventor(s)01 / Cook, Cary P.
1426 S. Bowen St.
Longmont, CO 80501 / US
 [2012/19]
Representative(s)Dehns
St. Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
[N/P]
Former [2019/23]Dehns
St. Brides House
10 Salisbury Square
London EC4Y 8JD / GB
Former [2012/17]Golding, Louise Ann
Dehns
St Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
Application number, filing date11187401.215.07.2004
[2012/17]
Priority number, dateUS20030489402P23.07.2003         Original published format: US 489402 P
[2012/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2444069
Date:25.04.2012
Language:EN
[2012/17]
Type: B1 Patent specification 
No.:EP2444069
Date:05.06.2019
Language:EN
[2019/23]
Search report(s)(Supplementary) European search report - dispatched on:EP28.03.2012
ClassificationIPC:A61K9/14, A61K9/16, A61K9/50, A61K9/51, A61K38/09, A61K38/11, A61K38/28, A61K38/31, A61K31/715, A61K47/54, A61K47/60
[2018/51]
CPC:
A61K9/1694 (EP,US); A61K31/715 (EP,US); A61K38/09 (EP,US);
A61K38/095 (EP,US); A61K38/28 (EP,US); A61K38/31 (EP,US);
A61K47/541 (EP,US); A61K47/60 (EP,US); A61K9/1647 (EP,US);
A61K9/5031 (EP,US); A61K9/5153 (EP,US) (-)
Former IPC [2012/17]A61K9/14, A61K9/16, A61K9/51, A61K38/00, A61K47/48
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2019/23]
Former [2012/17]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Zusammensetzung mit kontrollierter Freisetzung[2012/17]
English:Controlled release compositions[2012/17]
French:Compositions à libération contrôlée[2012/17]
Examination procedure25.10.2012Amendment by applicant (claims and/or description)
25.10.2012Examination requested  [2012/49]
29.01.2013Despatch of a communication from the examining division (Time limit: M06)
01.08.2013Reply to a communication from the examining division
03.07.2015Despatch of a communication from the examining division (Time limit: M06)
15.02.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
25.04.2016Reply to a communication from the examining division
17.04.2018Despatch of a communication from the examining division (Time limit: M06)
29.10.2018Reply to a communication from the examining division
14.12.2018Communication of intention to grant the patent
24.04.2019Fee for grant paid
24.04.2019Fee for publishing/printing paid
24.04.2019Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP04778361.8  / EP1656115
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040778361) is  22.10.2009
Opposition(s)06.03.2020No opposition filed within time limit [2020/20]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
25.04.2016Request for further processing filed
25.04.2016Full payment received (date of receipt of payment)
Request granted
09.05.2016Decision despatched
Fees paidRenewal fee
01.03.2012Renewal fee patent year 03
01.03.2012Renewal fee patent year 04
01.03.2012Renewal fee patent year 05
01.03.2012Renewal fee patent year 06
01.03.2012Renewal fee patent year 07
01.03.2012Renewal fee patent year 08
23.07.2012Renewal fee patent year 09
22.07.2013Renewal fee patent year 10
23.07.2014Renewal fee patent year 11
23.07.2015Renewal fee patent year 12
22.07.2016Renewal fee patent year 13
24.07.2017Renewal fee patent year 14
27.07.2018Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.07.2004
AT05.06.2019
CY05.06.2019
CZ05.06.2019
DK05.06.2019
EE05.06.2019
FI05.06.2019
MC05.06.2019
PL05.06.2019
RO05.06.2019
SI05.06.2019
SK05.06.2019
TR05.06.2019
LU15.07.2019
BE31.07.2019
BG05.09.2019
GR06.09.2019
PT07.10.2019
[2021/32]
Former [2021/26]AT05.06.2019
CY05.06.2019
CZ05.06.2019
DK05.06.2019
EE05.06.2019
FI05.06.2019
MC05.06.2019
PL05.06.2019
RO05.06.2019
SI05.06.2019
SK05.06.2019
TR05.06.2019
LU15.07.2019
BE31.07.2019
BG05.09.2019
GR06.09.2019
PT07.10.2019
Former [2020/25]AT05.06.2019
CZ05.06.2019
DK05.06.2019
EE05.06.2019
FI05.06.2019
MC05.06.2019
PL05.06.2019
RO05.06.2019
SI05.06.2019
SK05.06.2019
TR05.06.2019
LU15.07.2019
BE31.07.2019
BG05.09.2019
GR06.09.2019
PT07.10.2019
Former [2020/22]AT05.06.2019
CZ05.06.2019
DK05.06.2019
EE05.06.2019
FI05.06.2019
MC05.06.2019
RO05.06.2019
SK05.06.2019
TR05.06.2019
BG05.09.2019
GR06.09.2019
PT07.10.2019
Former [2020/17]AT05.06.2019
CZ05.06.2019
EE05.06.2019
FI05.06.2019
MC05.06.2019
RO05.06.2019
SK05.06.2019
TR05.06.2019
BG05.09.2019
GR06.09.2019
PT07.10.2019
Former [2020/11]AT05.06.2019
CZ05.06.2019
EE05.06.2019
FI05.06.2019
RO05.06.2019
SK05.06.2019
BG05.09.2019
GR06.09.2019
PT07.10.2019
Former [2020/10]AT05.06.2019
CZ05.06.2019
FI05.06.2019
RO05.06.2019
BG05.09.2019
GR06.09.2019
PT07.10.2019
Former [2020/09]CZ05.06.2019
FI05.06.2019
BG05.09.2019
GR06.09.2019
Former [2019/51]FI05.06.2019
BG05.09.2019
GR06.09.2019
Former [2019/48]FI05.06.2019
Documents cited:Search[X]WO9832423  (TAKEDA CHEMICAL INDUSTRIES LTD [JP], et al) [X] 1-11 * page 10 - page 14 * * page 10, line 36 * * page 48 - page 49; example 11 *;
 [X]US5876761  (BODMER DAVID [CH], et al) [X] 1-11 * examples 1-10 *;
 [XI]US6120805  (SPENLEHAUER GILLES [FR], et al) [X] 1-9,11 * column 4; example 1 * [I] 10;
 [E]WO2004078147  (PR PHARMACEUTICALS [US], et al) [E] 1-9,11 * page 27; example 3 *
ExaminationUS2003134800
by applicantUS5776885
 WO2004US11485
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.